Jonathan Langley

Jonathan Langley's work experience is as follows:

- Jonathan is currently working as the Vice President Medical Affairs at Aerovate Therapeutics, Inc. since December 2021.

- Prior to that, they served as a Non-Executive Director at ATXA Therapeutics Limited starting in July 2020.

- From November 2018 to November 2021, they worked at Galapagos as the Medical Affairs Head, Fibrosis.

- At GSK, they held several positions including Global Medical Affairs Lead for PAH & mepolizumab/EGPA from an unknown start date to October 2018, Global Medical Affairs Lead for PAH from November 2015 to an unknown end date, Scientific Affairs Director for Europe/Global from December 2011 to November 2015, and Medical Affairs Manager for Europe from September 2008 to November 2011.

- Jonathan worked at Actelion as a (Senior) Medical Affairs Manager from August 2004 to August 2008.

- Their career at Pfizer started in September 1997 as a Clinical Research Technician and later became a Medical Information Specialist for Neurology from November 2000 to July 2004.

Jonathan Langley attended King's College London. No specific start or end dates were provided for their education at this institution, and no information was provided regarding the degree they pursued or the field of study they focused on.